News & Analysis as of

Senate Finance Committee Drug Pricing

Wiley Rein LLP

Health Care AI and Drug Prices: Highlights From Two Senate Hearings

Wiley Rein LLP on

Health Care was a hot topic in the U.S. Senate on February 8, as two important Senate Committees – the Committee on Finance and the Committee on Health, Education, Labor, and Pensions (HELP) – held hearings, respectively, on...more

Wiley Rein LLP

Senate Finance Committee Releases Framework for Pharmacy Benefit Manager Reform

Wiley Rein LLP on

On April 20, 2023, Senate Finance Committee Chair Senator Ron Wyden (D-OR) and Ranking Member Mike Crapo (R-ID) released a bipartisan framework for reducing prescription drug costs and implementing pharmacy benefit manager...more

ArentFox Schiff

Senate Finance Committee Holds Confirmation Hearing For Top Biden HHS Nominees

ArentFox Schiff on

Deputy Secretary and CMS Administrator Picks Would Fill Two Critical Policy Positions - On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated...more

Mintz - Health Care Viewpoints

ML Strategies Health Care Preview - September 2019 #2

Congress returns to session this week with days to pass a continuing resolution (CR) to keep the government open. The House of Representatives passed a short term bill to keep the government open through November 21st, but a...more

Baker Donelson

Grassley Finance Committee Agenda Highlights Oversight

Baker Donelson on

Senator Charles "Chuck" Grassley, Chairman of the Senate Finance committee which has jurisdiction over Medicare and Medicaid as well as taxation and other revenue measures, has less than 18 months left in his tenure as...more

Foley Hoag LLP - Medicaid and the Law

Senate Finance Committee Proposes Significant Drug Pricing Reforms in Medicaid

On July 25, 2019 the Senate Finance Committee voted to advance their long-awaited drug pricing package to the Senate floor (we anticipate a Floor vote sometime this Fall). The Prescription Drug Pricing Reduction Act (PDPRA)...more

Manatt, Phelps & Phillips, LLP

Congress and Administration Consider Significant Drug Pricing Policy Changes

In both chambers of Congress, passing legislation to bring down drug prices is a policy priority—and the savings from such possible legislation is slated to offset other healthcare legislative proposals (such as addressing...more

Mintz - Health Care Viewpoints

ML Strategies Health Care Preview - July 2019

Welcome back. This week, the Senate Finance Committee is set to meet privately to discuss the drug pricing legislation being developed by the committee. All signs point to a deal being close with a few outstanding provisions,...more

Mintz - Health Care Viewpoints

Health Care Weekly Preview from ML Strategies – March 2019

This week, Congressional oversight of prescription drug prices will continue with two hearings in the Senate Special Committee on Aging, which is led by Sen. Susan Collins (R-ME) and Bob Casey (D-PA). The hearings will offer...more

Mintz - Health Care Viewpoints

Five Takeaways from the Senate Finance Committee’s Hearing on Drug Pricing

On February 26, 2019, the Senate Finance Committee heard testimony from top executives representing seven high-profile drug manufacturers. This hearing was the second to examine drug pricing in America. The Committee’s...more

Mintz - Health Care Viewpoints

What Does the Future Hold for Drug Pricing?

On Tuesday, executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee on rising prescription drug prices. While the hearing was expected to be packed with fireworks as...more

BakerHostetler

The Weekly Hill Update

BakerHostetler on

Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES - Furloughed federal employees are returning to work for at least three weeks after President Trump signed a...more

Foley & Lardner LLP

Health Care Policy Newsletter - July 2018

Foley & Lardner LLP on

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more

Foley & Lardner LLP

Health Care Policy Newsletter - June 2018 pt 2

Foley & Lardner LLP on

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more

Mintz - Health Care Viewpoints

Health Care Weekly Preview from ML Strategies – June 2018

Welcome back. This week, the Senate Finance Committee will mark up an opioid package. The final text will be important for gauging how close the Senate is to the House package. The House will begin voting on dozens of...more

Akin Gump Strauss Hauer & Feld LLP

What's New In Washington - April 2018

Congress returned from its spring recess with a host of issues to address—trade, Trump administration nominations and opioid legislation sitting atop the priority list. Given the ongoing data scandal at Facebook, privacy...more

Holland & Knight LLP

HHS Nominee Alex Azar Testifies Before Senate HELP

Holland & Knight LLP on

The Senate Health, Education, Labor, & Pensions (HELP) Committee held the first hearing on the confirmation for Secretary of Health and Human Services (HHS) nominee Alex Azar on Wednesday, November 29. Notably, only the...more

17 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide